Bayer’s MRI Contrast Agent Gets FDA Approval

genexi (31)in #cardiology • 6 years ago

Bayer’s Gadavist MRI Contrast Agent Gadavist (gadobutrol) has been approved by FDA for coronary artery disease (CAD). The agency has previously greenlit the gadobutrol injection for use in MRI of the central nervous system and breasts.